Skip to content
Broadly Epi

Broadly Epi

Epidemiology, Broadly Speaking

  • Home
  • Rent-A-Scientist
  • Software
    • Broadly Epi MMWR Archive Database
    • HSE Specialty Care Finder
  • Data Rebellion
    • Social Vulnerability Index Archive and Data Mart
  • Care Resources
    • LGBTQIA+ Health Resources
    • Health Care Affordability Resources
    • List of Resources for People Who Use Drugs
  • Blog
    • Epi Explained: Simplified Epidemiology Concepts
    • MMWR Booster: Simplified Research
    • Python Tutorials
    • R Tutorials
    • Emerging Study
    • Community Experts
  • Contact Us

Tag: COVID

Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 / Weekly / May 6, 2022 / 71(18);633–637

Posted on May 18, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Increased Protection with Boosters: Additional primary or booster COVID-19 vaccine doses significantly enhance protection against the Omicron variant in nursing home residents, showing a relative vaccine effectiveness

Read More
MMWR Booster 2022, COVID, Infectious Disease, MMWR Boosters, Vaccine Leave a comment

Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021/ Weekly / May 27, 2022 / 71(21);713–717

Posted on April 29, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Increased Incidence of Post-COVID Conditions: Adults who survived COVID-19 are at a higher risk of developing conditions such as pulmonary embolism and respiratory symptoms, with 38% of

Read More
MMWR Booster 2022, COVID, Infectious Disease, Long COVID, MMWR Boosters, post-COVID Leave a comment

MMWR Booster for: Use of an Additional Updated 2023–2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 / Weekly / April 25, 2024 / 73(16);377–381

Posted on April 26, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways New Vaccination Recommendation: As of February 28, 2024, the Advisory Committee on Immunization Practices (ACIP) recommends an additional dose of the updated (2023–2024 Formula) COVID-19 vaccine for

Read More
MMWR Booster 2024, COVID, Infectious Disease, MMWR Boosters Leave a comment

MMWR Booster for: COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19–Associated Hospitalization Among Residents in Nursing Homes — National Healthcare Safety Network, United States, October 2023–February 2024 / Weekly / April 18, 2024 / 73(15);339–344

Posted on April 19, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways High Infection and Hospitalization Rates: Throughout the study period, SARS-CoV-2 infection rates ranged from 61.4 to 133.8 per 10,000 nursing home residents, with a peak of 133.8

Read More
MMWR Booster 2024, COVID, Infectious Disease, LTCF, MMWR Boosters Leave a comment

MMWR Booster for: Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023 / Weekly / April 18, 2024 / 73(15);330–338

Posted on April 19, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Initial Vaccine Effectiveness: The original monovalent mRNA COVID-19 vaccine was 52% effective in preventing COVID-19-related hospitalization in children and adolescents when the last dose was received within

Read More
MMWR Booster 2024, COVID, Infectious Disease, MMWR Boosters, Pediatric Leave a comment

MMWR Booster for: COVID-19 Cases, Hospitalizations, and Deaths Among American Indian or Alaska Native Persons — Alaska, 2020–2021 / Weekly / June 3, 2022 / 71(22);730–733

Posted on April 17, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Disproportionately Higher COVID-19 Impact on AI/AN Persons: AI/AN individuals in Alaska experienced COVID-19 illness, hospitalization, and death rates approximately 2 to 3 times higher than White persons

Read More
MMWR Booster 2022, COVID, Infectious Disease, MMWR Boosters, Vaccination Leave a comment

MMWR Booster for: Ventilation Improvement Strategies Among K–12 Public Schools — The National School COVID-19 Prevention Study, United States, February 14–March 27, 2022 / Weekly / June 10, 2022 / 71(23);770–775

Posted on April 14, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Lower-cost Ventilation Strategies Predominate: The majority of U.S. K–12 public schools reported using lower-cost ventilation improvement strategies, such as relocating activities outdoors and opening doors or windows.

Read More
MMWR Booster 2022, COVID, MMWR Boosters, Pediatric, School, Ventilation Leave a comment

MMWR Booster for: COVID-19 Vaccination Coverage, by Race and Ethnicity — National Immunization Survey Adult COVID Module, United States, December 2020–November 2021 / Weekly / June 10, 2022 / 71(23);757–763

Posted on April 13, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Initial Disparities in Vaccination Coverage: Early in the vaccination campaign, Asian and non-Hispanic White adults had the highest COVID-19 vaccination coverage, while coverage was lower among Hispanic,

Read More
MMWR Booster 2022, COVID, Infectious Disease, MMWR Boosters, Vaccine Leave a comment

MMWR Booster for: Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine — Oregon, June 2021–December 2022 / Weekly / April 11, 2024 / 73(14);317–320

Posted on April 12, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Low incidence of sudden cardiac death post-vaccination: Among 1,292 deaths of Oregon residents aged 16–30 during the study period, only three sudden deaths occurred within 100 days

Read More
MMWR Booster 2024, COVID, Infectious Disease, MMWR Boosters, Vaccine Leave a comment

MMWR Booster for: COVID-19 Vaccination Coverage — World Health Organization African Region, 2021–2023 / Weekly / April 11, 2024 / 73(14);307–311

Posted on April 12, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Significant Increase in Vaccine Supply: From 2021 to 2023, COVID-19 vaccine doses received in the African Region increased from 321 million to 860 million, with 646 million

Read More
MMWR Booster 2024, COVID, Infectious Disease, MMWR Boosters, Vaccine Leave a comment
  • ← Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 8
  • Next →

Search

Categories

Recent Posts

  • Community Experts Issue 3: Rowan Odom’s Story – Living with an Undiagnosed Chronic Illness February 1, 2025
  • MMWR Booster for: Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021 / February 25, 2022 / 71(8);290–292 January 11, 2025
  • MMWR Booster for: Screening Programs for SARS-CoV-2 Infections on a University Campus — Austin, Texas, September 30–November 30, 2020 / September 3, 2021 / 70(35);1201–1205 January 10, 2025
  • MMWR Booster for: Results from a Test-to-Release from Isolation Strategy Among Fully Vaccinated National Football League Players and Staff Members with COVID-19 — United States, December 14–19, 2021 / February 25, 2022 / 71(8);299–305 January 10, 2025
  • MMWR Booster for: Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break — Chicago, Illinois, March–May 2021 / September 3, 2021 / 70(35);1195–1200 January 9, 2025
  • MMWR Booster for: Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 / March 4, 2022 / 71(9);352–358 January 9, 2025
  • MMWR Booster for: Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022 / February 25, 2022 / 71(8);285–289 January 8, 2025
  • MMWR Booster for: Evaluation of Syndromic Surveillance Data for Studying Harmful Algal Bloom-Associated Illnesses — United States, 2017–2019 / September 3, 2021 / 70(35);1191–1194 January 8, 2025
  • MMWR Booster for: Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022 / March 4, 2022 / 71(9);347–351 January 7, 2025
  • MMWR Booster for: National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2020 / September 3, 2021 / 70(35);1183–1190 January 7, 2025
  • Github
  • BlueSky
  • Threads
  • LinkedIn

Notifications